FDA approves Impavido to treat tropical disease leishmaniasis

The U.S. Food and Drug Administration has approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis.Leishmaniasis is a disease caused by Leishmania, a parasite which is transmitted to humans through sand fly bites. The disease occurs primarily in people who live in the tropics and subtropics. Most U.S. patients acquire leishmaniasis overseas.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Tropical Diseases Source Type: news